|
" Imaging of Gastrointestinal Tract Tumors "
Jean-Noel Bruneton
| Document Type
|
:
|
BL
|
| Record Number
|
:
|
731633
|
| Doc. No
|
:
|
b551419
|
| Main Entry
|
:
|
Jean-Noel Bruneton
|
| Title & Author
|
:
|
Imaging of Gastrointestinal Tract Tumors\ Jean-Noel Bruneton
|
| Publication Statement
|
:
|
Berlin Springer Berlin, 2013
|
| Page. NO
|
:
|
XIX, 281 Seiten in 1 Teil XIX, 281 Seiten 267 Figuren, 25 tables, 25 schw.-w. Tabellen 242 x 170 mm
|
| ISBN
|
:
|
3642838278
|
|
|
:
|
: 9783642838279
|
| Contents
|
:
|
Benign Tumors.- 1 Benign Epithelial Tumors.- 1.1 Esophagus.- 1.1.1 General Features.- 1.1.2 Imaging.- 1.2 Stomach.- 1.2.1 General Features.- 1.2.2 Imaging.- 1.2.3 Differential Diagnosis.- 1.3 Small Intestine.- 1.3.1 General Features.- 1.3.2 Imaging.- 1.3.3 Differential Diagnosis.- 1.4 Colon and Rectum.- 1.4.1 General Features.- 1.4.2 Imaging.- 1.4.3 Differential Diagnosis.- 1.4.4 Conclusion.- 1.5 References.- 2 Polyposis.- 2.1 Hereditary Polyposis Syndromes.- 2.1.1 Familial Multiple Polyposis.- 2.1.2 Other Hereditary Polypses.- 2.2 Non-hereditary Polyposes.- 2.2.1 Proliferation of Hyperplastic Polyps.- 2.2.2 Cronkhite-Canada Syndrome.- 2.2.3 Differential Diagnosis.- 2.3 References.- 3 Leiomyoma.- 3.1 Esophagus.- 3.1.1 General Features.- 3.1.2 Imaging.- 3.2 Stomach.- 3.2.1 General Features.- 3.2.2 Imaging.- 3.3 Small Intestine.- 3.3.1 General Features.- 3.3.2 Imaging.- 3.4 Colon and Rectum.- 3.4.1 General Features.- 3.4.2 Imaging.- 3.5 Conclusion.- 3.6 References.- 4 Lipoma.- 4.1 General Anatomic Features.- 4.2 Esophagus.- 4.3 Stomach.- 4.4 Small Intestine.- 4.5 Colon and Rectum.- 4.6 References.- 5 Benign Neurogenic Tumors.- 5.1 Neurogenic Gastric Tumors (Excluding von Recklinghausen's Disease).- 5.1.1 General Features.- 5.1.2 Imaging.- 5.2 Neurogenic Intestinal Tumors (Excluding von Recklinghausen's Disease).- 5.2.1 General Features.- 5.2.2 Imaging.- 5.3 Solitary Benign Neurogenic Tumors of the Esophagus, Colon, and Rectum.- 5.3.1 Esophagus.- 5.3.2 Colon and Rectum.- 5.4 Benign Neurogenic Tumors in von Recklinghausen's Disease.- 5.4.1 Gastric Involvement by von Recklinghausen's Disease.- 5.4.2 Intestinal Involvement by von Recklinghausen's Disease.- 5.5 Granular Cell Tumors.- 5.5.1 General Features.- 5.5.2 Esophagus.- 5.6 References.- 6 Benign Vascular Tumors.- 6.1 General Features.- 6.2 Gastrointestinal Hemangiomas.- 6.2.1 Esophagus.- 6.2.2 Stomach.- 6.2.3 Small Intestine.- 6.2.4 Colon and Rectum.- 6.3 Lymphangiomas.- 6.4 References.- 7 Benign Fibrous Tumor Tissues.- 7.1 Esophagus.- 7.2 Stomach.- 7.3 Small Intestine.- 7.4 Colon and Rectum.- 7.5 Conclusion.- 7.6 References.- 8 Aberrant Pancreas.- 8.1 General Features.- 8.2 Imaging.- 8.3 Conclusion.- 8.4 References.- 9 Endometriosis.- 9.1 General Features.- 9.2 Imaging.- 9.3 References.- Malignant Tumors.- 10 Carcinoma of the Esophagus.- 10.1 Pathology.- 10.1.1 Epidemiology.- 10.1.2 Pathogenesis.- 10.2 Anatomic Features.- 10.2.1 Macroscopic Features.- 10.2.2 Location.- 10.2.3 Histology.- 10.2.4 Patterns of Spread.- 10.2.5 Evolution.- 10.2.6 TNM Classification.- 10.3 Clinical Symptoms and Endoscopy.- 10.3.1 Clinical Symptoms.- 10.3.2 Endoscopy.- 10.4 Diagnostic Imaging.- 10.4.1 Standard Chest X-rays.- 10.4.2 Barium Esophagography.- 10.4.3 Computed Tomography.- 14.4.4 Ultrasonography.- 10.4.5 Other Techniques.- 10.5 Prognostic Factors.- 10.6 Therapeutic Options.- 10.6.1 Surgery.- 10.6.2 Radiotherapy.- 10.6.3 Local Palliative Therapy.- 10.7 Post-therapy Imaging Studies and Diagnosis of Complications.- 10.7.1 Normal Postoperative Appearance.- 10.7.2 Early Postoperative Complications.- 10.7.3 Late Postoperative Complications.- 10.7.4 Surveillance After Radiotherapy.- 10.7.5 Surveillance After Other Types of Treatment.- 10.8 Adenocarcinoma of the Esophagus.- 10.8.1 Radiographic Features.- 10.8.2 Differences Between Adenocarcinoma and Epidermoid Cancer of the Esophagus 102 10.8.3 Adenocarcinoma of the Esophagus and Gastric Adenocarcinoma.- 10.9 Conclusion.- 10.10 References.- 11 Adenocarcinoma of the Stomach.- 11.1 Epidemiology.- 11.1.1 Frequency.- 11.2 Pathogenesis.- 11.2.1 Endogenous Factors.- 11.2.2 Environmental Factors.- 11.3 Pathologic Findings.- 11.3.1 Gross Anatomy.- 11.3.2 Microscopic Features.- 11.3.3 Mode of Spread.- 11.3.4 Classifications of Gastric Adenocarcinoma.- 11.4 Diagnostic Data Other than Imaging.- 11.4.1 Circumstances of Discovery and Screening.- 11.4.2 Clinical Symptoms.- 11.4.3 Endoscopy.- 11.5 Imaging Studies.- 11.5.1 Contrast Studies.- 11.5.2 Ultrasonography.- 11.5.3 Computed Tomography.- 11.6 Treatment and Prognosis.- 11.6.1 Surgical Management of Gastric Adenocarcinoma.- 11.6.2 Radiotherapy.- 11.6.3 Chemotherapy.- 11.6.4 Indications.- 11.6.5 Prognostic Factors.- 11.6.6 Survival.- 11.7 Patient Follow-up.- 11.7.1 Clinical Pictures and Frequency of Complications.- 11.7.2 Disease Recurrence.- 11.7.3 Follow-up Algorithm.- 11.7.4 Imaging Studies for Follow-up of Patients with Gastric Adenocarcinoma.- 11.8 Cancer of the Cardia.- 11.8.1 General Features.- 11.8.2 Imaging.- 11.9 Conclusion.- 11.10 References.- 12 Adenocarcinoma of the Small Intestine.- 12.1 General Features.- 12.2 Imaging.- 12.3 Conclusion.- 12.4 References.- 13 Adenocarcinoma of the Colon and Rectum.- 13.1 General Features.- 13.1.1 Epidemiology.- 13.1.2 Pathologic Anatomy.- 13.1.3 Clinical Study.- 13.1.4 Diagnosis by Non-imaging Techniques.- 13.1.5 Therapeutic Options.- 13.1.6 Results and Prognosis.- 13.2 Pretherapy Staging of Colorectal Adenocarcinomas.- 13.2.1 Barium Enema Examination.- 13.2.2 Ultrasonography.- 13.2.3 Computed Tomography.- 13.3 Post-therapy Follow-up.- 13.3.1 Post-therapy Follow-up Examinations.- 13.3.2 Anterior Resection.- 13.3.3 Abdominoperineal Resection.- 13.3.4 Pelvic Exenteration.- 13.3.5 Hepatic Metastases.- 13.3.6 Non-curative Treatment.- 13.4 Screening for Colorectal Cancer.- 13.4.1 Occult Fecal Blood Tests.- 13.4.2 High-risk Patients.- 13.5 References.- 14 Cancer of the Anal Canal.- 14.1 Epidemiology.- 14.2 Pathogenesis.- 14.2.1 Gross Features.- 14.2.2 Histology.- 14.2.3 Mode of Spread.- 14.2.4 Histoprognosis.- 14.3 Clinical Features.- 14.4 Imaging.- 14.5 Treatment.- 14.5.1 Radiotherapy.- 14.5.2 Surgery.- 14.5.3 Therapeutic Options.- 14.5.4 Post-therapy Follow-up.- 14.6 Conclusion.- 14.7 References.- 15 Leiomyosarcoma.- 15.1 Esophagus.- 15.1.1 General Features.- 15.1.2 Imaging.- 15.2 Stomach.- 15.2.1 General Features.- 15.2.2 Imaging.- 15.3 Small Intestine.- 15.3.1 General Features.- 15.3.2 Imaging.- 15.4 Colon and Rectum.- 15.4.1 General Features.- 15.4.2 Imaging.- 15.5 Conclusion.- 15.6 References.- 16 Lymphomas.- 16.1 Non-Hodgkin's Lymphoma.- 16.1.1 Esophagus.- 16.1.2 Stomach.- 16.1.3 Small Intestine.- 16.1.4 Colon and Rectum.- 16.2 Hodgkin's Disease.- 16.2.1 Esophagus.- 16.2.2 Stomach.- 16.2.3 Small Intestine.- 16.2.4 Colon and Rectum.- 16.3 Conclusion.- 16.4 References.- 17 Metastases.- 17.1 Esophagus.- 17.1.1 Clinical Features.- 17.1.2 Radiologic Features.- 17.2 Stomach.- 17.2.1 Clinical Features.- 17.2.2 Radiologic Features.- 17.3 Small Intestine.- 17.3.1 Clinical Features.- 17.3.2 Radiologis Features.- 17.4 Colon and Rectum.- 17.4.1 Clinical Features.- 17.4.2 Radiologic Features.- 17.5 Conclusion.- 17.6 References.- 18 Kaposi's Sarcoma.- 18.1 General Features.- 18.2 Imaging.- 18.3 References.- 19 Malignant Neurogenic Tumors.- 19.1 Stomach (Excluding von Recklinghausen's Disease).- 19.1.1 General Features.- 19.1.2 Imaging.- 19.2 Small Intestine (Excluding von Recklinghausen's Disease).- 19.2.1 General Features.- 19.2.2 Imaging.- 19.3 Malignant Neurogenic Tumors in von Recklinghausen's Disease.- 19.4 References.- 20 Primary Malignant Melanoma of the Gastrointestinal Tract.- 20.1 Pathology.- 20.2 General Features.- 20.3 Gastrointestinal Sites.- 20.4 Primary Melanoma of the Esophagus.- 20.5 Anorectal Melanoma.- 20.6 Conclusion.- 20.7 References.- 21 Malignant Fibrous Histiocytoma.- 21.1 General Features.- 21.2 Imaging.- 21.3 Conclusion.- 21.4 References.- Tumors with an Indeterminate Prognosis.- 22 Carcinoid Tumors.- 22.1 General Features.- 22.1.1 Gross Features.- 22.1.2 Clinical Features.- 22.1.3 Diagnosis by Techniques Other than Imaging.- 22.1.4 Evolution and Prognosis.- 22.2 Imaging.- 22.2.1 Small Intestine.- 22.2.2 Rectum.- 22.2.3 Colon.- 22.2.4 Stomach.- 22.2.5 Other Anatomic Sites.- 22.3 Conclusion.- 22.4 References.- 23 Leiomyoblastoma.- 23.1 Stomach.- 23.1.1 General Features.- 23.1.2 Imaging.- 23.2 Extragastric Sites.- 23.3 References.- 24 Hemangiopericytoma.- 24.1
|
|
|
:
|
General Features.- 24.2 Imaging.- 24.3 Conclusion.- 24.4 References.- 25 Subject Index.
|
| LC Classification
|
:
|
RC280.D5J436 2013
|
| Added Entry
|
:
|
Jean-Noel Bruneton
|
| |